Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Interest Coverage Ratio (2018 - 2025)

10x Genomics' Interest Coverage Ratio history spans 8 years, with the latest figure at 10747.33 for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 151.81% to 10747.33 in Q3 2025 year-over-year; TTM through Jun 2025 was 20105.2, a 12.66% increase, with the full-year FY2024 number at 48639.75, down 504.95% from a year prior.
  • Interest Coverage Ratio hit 10747.33 in Q3 2025 for 10x Genomics, up from 10042.0 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for TXG hit a ceiling of 10747.33 in Q3 2025 and a floor of 94795.0 in Q3 2023.
  • Historically, Interest Coverage Ratio has averaged 13057.14 across 5 years, with a median of 350.84 in 2022.
  • Biggest five-year swings in Interest Coverage Ratio: tumbled 26919.28% in 2023 and later soared 151.81% in 2025.
  • Tracing TXG's Interest Coverage Ratio over 5 years: stood at 72.95 in 2021, then plummeted by 153.28% to 184.77 in 2022, then crashed by 3633.6% to 6898.5 in 2023, then plummeted by 200.68% to 20742.5 in 2024, then soared by 151.81% to 10747.33 in 2025.
  • Business Quant data shows Interest Coverage Ratio for TXG at 10747.33 in Q3 2025, 10042.0 in Q2 2025, and 20742.5 in Q3 2024.